Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.

Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
复制标题

DOI:
10.1148/radiol.2021211808
复制
发表时间:
2022-05
期刊:
影响因子:
19.7
通讯作者:
Sprague BL
Sprague BL
中科院分区:
医学1区
文献类型:
--
作者:
Lowry KP;Bissell MCS;Miglioretti DL;Kerlikowske K;Alsheik N;Macarol T;Bowles EJA;Buist DSM;Tosteson ANA;Henderson L;Herschorn SD;Wernli KJ;Weaver DL;Stout NK;Sprague BL

文献摘要

参考文献

被引文献

相似文献

新冠肺炎的大流行减少了乳房X光检查的使用,可能会推迟乳腺癌的诊断。按检测模式(筛查发现与有症状)和妇女特征检查乳房活检建议和新冠肺炎大流行之前和期间诊断的乳腺癌。在这项对前瞻性收集的数据的二次分析中,对2019年1月至2020年9月期间乳腺癌监测联盟的66个机构进行了检查,其中包括美国乳房X光检查后的每月乳房活组织检查建议,或两者都进行了随后的活体检查。在大流行期间(2020年3月至2020年9月),建议和进行的每月和累计活检数量以及随后诊断的癌症数量与流行期前的数据进行了比较,使用的是WALDχ2测试。分析按检测模式和种族或民族进行分层。从2019年1月到2020年9月,建议和进行了17次 728活检,诊断出6,009例癌症。从2020年3月到9月,与2019年同期相比,确诊为癌症的乳房活检建议大幅减少(2020年1650项建议比2019年2171项建议[减少24%],P<.001),主要是因为筛查发现的癌症(2020年722例癌症比2019年1169例癌症[减少38%],P<.001)与有症状的癌症(2020年895例癌症比2019年965例癌症[减少7%],P=.27)。癌症诊断的降幅最大的是亚洲女性(2020年67例诊断,2019年142例[减少53%],P=.06)和西班牙裔(2020年82例诊断,2019年145例[减少43%],P=.13),其次是黑人女性(2020年210例诊断,2019年287例诊断[减少27%],P=.21)。非西班牙裔白人女性的降幅最小(2020年为1128例诊断,2019年为1357例[减少17%],P=0.09)。与2019年同期相比,2020年3月至9月新冠肺炎大流行期间,确诊为癌症的乳腺活检大幅减少,其中亚裔和西班牙裔女性降幅最大,其次是黑人女性。©RSNA,2022在线补充材料可用于本文。另见本期海勒的社论。
The COVID-19 pandemic reduced mammography use, potentially delaying breast cancer diagnoses. To examine breast biopsy recommendations and breast cancers diagnosed before and during the COVID-19 pandemic by mode of detection (screen detected vs symptomatic) and women's characteristics. In this secondary analysis of prospectively collected data, monthly breast biopsy recommendations after mammography, US, or both with subsequent biopsy performed were examined from 66 facilities of the Breast Cancer Surveillance Consortium between January 2019 and September 2020. The number of monthly and cumulative biopsies recommended and performed and the number of subsequent cancers diagnosed during the pandemic period (March 2020 to September 2020) were compared with data from the prepandemic period using Wald χ2 tests. Analyses were stratified by mode of detection and race or ethnicity. From January 2019 to September 2020, 17 728 biopsies were recommended and performed, with 6009 cancers diagnosed. From March to September 2020, there were substantially fewer breast biopsy recommendations with cancer diagnoses when compared with the same period in 2019 (1650 recommendations in 2020 vs 2171 recommendations in 2019 [24% fewer], P < .001), predominantly due to fewer screen-detected cancers (722 cancers in 2020 vs 1169 cancers in 2019 [38% fewer], P < .001) versus symptomatic cancers (895 cancers in 2020 vs 965 cancers in 2019 [7% fewer], P = .27). The decrease in cancer diagnoses was largest in Asian (67 diagnoses in 2020 vs 142 diagnoses in 2019 [53% fewer], P = .06) and Hispanic (82 diagnoses in 2020 vs 145 diagnoses in 2019 [43% fewer], P = .13) women, followed by Black women (210 diagnoses in 2020 vs 287 diagnoses in 2019 [27% fewer], P = .21). The decrease was smallest in non-Hispanic White women (1128 diagnoses in 2020 vs 1357 diagnoses in 2019 [17% fewer], P = .09). There were substantially fewer breast biopsies with cancer diagnoses during the COVID-19 pandemic from March to September 2020 compared with the same period in 2019, with Asian and Hispanic women experiencing the largest declines, followed by Black women. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Heller in this issue.
DOI: 10.1002/cncr.33460
发表时间: 2021-06-15
期刊: Cancer
影响因子: 6.2
作者:
Nyante SJ;Benefield TS;Kuzmiak CM;Earnhardt K;Pritchard M;Henderson LM
通讯作者: Henderson LM
DOI: 10.1053/j.gastro.2020.10.030
发表时间: 2021-03
期刊: Gastroenterology
影响因子: 29.4
作者:
National Cancer Institute’s PROSPR Consortium;Corley DA;Sedki M;Ritzwoller DP;Greenlee RT;Neslund-Dudas C;Rendle KA;Honda SA;Schottinger JE;Udaltsova N;Vachani A;Kobrin S;Li CI;Haas JS
通讯作者: Haas JS
DOI: 10.1007/s10549-021-06252-1
发表时间: 2021-08
影响因子: 3.8
作者:
Miller MM;Meneveau MO;Rochman CM;Schroen AT;Lattimore CM;Gaspard PA;Cubbage RS;Showalter SL
通讯作者: Showalter SL
DOI: 10.1001/jamainternmed.2017.8549
发表时间: 2018-04-01
影响因子: 39
作者:
Buist, Diana S. M.;Abraham, Linn;Onega, Tracy
通讯作者: Onega, Tracy
DOI: 10.1016/j.breast.2020.08.014
发表时间: 2020-12-01
期刊: BREAST
影响因子: 3.9
作者:
Tsai, Huei-Yi;Chang, Yu-Ling;Chen, Fang-Ming
通讯作者: Chen, Fang-Ming